Merck & Co., Inc. is 143.1x more valuable than Pharvaris N.V. by market capitalization ($294.13 B vs $2.05 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PHVS | MRK |
|---|---|---|
| Market cap | $2.05 B | $294.13 B |
| US-listed rank | #2084 | #44 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | - | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 254 | 996 |
Merck & Co., Inc. is 143.1x more valuable than Pharvaris N.V. by market capitalization ($294.13 B vs $2.05 B).
Full pages: Pharvaris N.V. and Merck & Co., Inc., or browse the full rankings.